| R&D Directions provides insight into pharmaceutical
research and development, from discovery through clinical trials and submission.
Leaving the hard science to other publications, R&D Directions focuses
on pharmaceutical companies’ R&D business strategies and decisions.
Editorial content covers drugs, therapeutic categories, industry segments,
and strategies, and imparts extensive intelligence on products in the pipeline.
Although R&D Directions contains a wealth of medical and scientific
information, it is written in a non-clinical, non-technical style.
R&D Directions is read by senior managers, clinical
trials managers, clinical drug and academic researchers, medical directors,
data and project management, marketing and clinical monitoring professionals,
along with regulatory affairs, drug safety, and quality control professionals.
These professionals represent pharmaceutical and biotechnology companies,
clinical study sites, clinical labs, medical device manufacturers, academic
research institutions, data management firms, government agencies, and
contract research organizations, among others.
With a total circulation of more than 12,000*, R&D
Directions reaches more than 7,200* readers in pharmaceutical and biotechnology
companies; more than 40% of them are senior managers.* These subscribers
are key decision makers and constitute a prime audience for your marketing
communications message.
Since R&D Directions is the only publication of its
kind targeting business professionals in research and development environments,
the magazine provides a unique medium for your marketing message.
|
